Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediate-term efficacy, including virologic, biochemical, serologic, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung Won, Choi, Jonggi, Kim, Seung Up, Lim, Young-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273642/
https://www.ncbi.nlm.nih.gov/pubmed/34157830
http://dx.doi.org/10.3350/cmh.2021.0179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273642/
https://www.ncbi.nlm.nih.gov/pubmed/34157830
http://dx.doi.org/10.3350/cmh.2021.0179

Ejemplares similares